M 274 (Tamoxifen 20 mg)

Pill imprint M 274 has been identified as Tamoxifen citrate 20 mg.

Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer; breast cancer, metastatic; breast cancer, male; breast cancer, palliative (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for M 274 (Tamoxifen 20 mg)

Tamoxifen citrate 20 mg M 274 Front
Tamoxifen citrate 20 mg M 274 Back
Tamoxifen citrate 20 mg M 274
Tamoxifen citrate 20 mg M 274
Tamoxifen citrate
Imprint:
M
274
Strength:
20 mg
Color:
White
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Hormones/antineoplastics
Selective estrogen receptor modulators
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0274
Inactive Ingredients:
lactose anhydrous
silicon dioxide
crospovidone
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Suffering from knee pain? Find out how real people manage OA of the Knee. Watch Video

Close
Hide
(web1)